ARES Stock

Business

Analysts Bullish on Applied Materials as Chip Spending Surge Lifts Equipment Giant

Driven by a global wave of semiconductor investment, Applied Materials (AMAT) has received a series of analyst upgrades. Mizuho and Deutsche Bank are among those highlighting the company's strategic position to benefit from expansive fab construction in the U.S., Taiwan, and Japan, and its key role in next-generation chip technologies.

Feb 2, 2026

Business

Idorsia's Latin American Gambit: QUVIVIQ Deal with EMS Signals Strategic Shift Amid Pipeline Scrutiny

Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.

Feb 2, 2026

Business

Boeing's Record $682 Billion Order Backlog Signals Brighter Skies Ahead

While Boeing's Q4 revenue beat offers short-term relief, analysts point to its unprecedented order backlog as the true indicator of long-term recovery and growth potential in the commercial aviation sector.

Feb 2, 2026

Business

KPJ Healthcare Berhad Sees Accelerating Returns on Capital, Signaling Strategic Growth

The Malaysian healthcare provider KPJ Healthcare Berhad is demonstrating a strengthened capacity for profitable reinvestment, with its return on capital employed rising to 11% alongside significant capital expansion, pointing to a robust operational model.

Feb 2, 2026

Business

EG Industries Berhad's Capital Efficiency Surge Catches Investor Attention

The Malaysian electronics manufacturing services provider is showing compelling financial momentum, with its return on capital employed significantly outpacing industry averages and signaling potential for sustained growth.

Feb 2, 2026

Business

Glaukos Gains FDA Nod for Repeat iDose TR Implant, Bolstering Its Long-Term Glaucoma Platform Strategy

The FDA's approval of a repeat treatment protocol for Glaukos's iDose TR implant transforms it from a one-time procedure into a potential chronic therapy platform, reshaping its commercial narrative and investor calculus in the competitive glaucoma market.

Feb 2, 2026

World

From Sheds to Battlefields: How Europe's $920 Billion Defense Push Is Opening Doors for Startups

Faced with the realities of modern warfare in Ukraine, NATO is fast-tracking innovation, creating an unprecedented opportunity for agile tech founders to access a once-closed defense market.

Feb 2, 2026

Business

Davos Clash: Jamie Dimon's Heated Confrontation with Coinbase CEO Exposes Deep Rift Over Crypto's Future

A reported fiery exchange between JPMorgan's Jamie Dimon and Coinbase's Brian Armstrong at the World Economic Forum lays bare the intensifying battle between traditional finance and the crypto industry over regulation, deposits, and the future of money.

Feb 2, 2026

Business

Beyond the Hype: Marvell Technology Emerges as a Stealth AI Infrastructure Powerhouse

While investor attention fixates on flashier names, Marvell Technology's critical role in custom AI chips and data center infrastructure positions it for explosive growth, making its current valuation a potential opportunity.

Feb 2, 2026

Business

Trump's Second Term: A Windfall for Tech Titans as Musk, Bezos, Zuckerberg Add Billions

An analysis of wealth accumulation among the world's top billionaires reveals staggering gains during the current presidential term, with policy and market dynamics fueling unprecedented fortunes.

Feb 2, 2026

Business

Beyond the Giants: How FTEC and XLK ETFs Offer Divergent Paths to Tech Investing

While both ETFs target the high-flying U.S. technology sector, a closer look reveals critical distinctions in diversification, concentration risk, and liquidity that could sway long-term portfolio outcomes.

Feb 2, 2026

World

India Weighs Social Media Ban for Under-16s as Lawmaker Cites Data Exploitation and Youth Safety

A key ally of Prime Minister Narendra Modi has proposed legislation to prohibit social media access for children under 16, framing the move as a response to digital addiction and the exploitation of Indian user data by foreign tech giants, amid a growing global regulatory push.

Jan 31, 2026

Business

Musk's Weekend Focus: Tesla's Future Hinges on AI Chip Breakthrough, Not Cars

In a revealing moment during Tesla's earnings call, Elon Musk disclosed that his Saturdays are dedicated to the company's next-generation AI5 chip project, signaling a fundamental strategic shift from automaker to vertically integrated AI hardware powerhouse.

Jan 31, 2026

Business

Alm. Brand's Record Dividend and Earnings Beat: A Turning Point for the Bull Thesis?

Alm. Brand A/S posts robust Q4 2025 results, with net income soaring to DKK 337 million and proposing a record dividend. While underlining its shareholder return strategy, the market grapples with valuation concerns and execution risks in a softening share price environment.

Jan 31, 2026

Business

Terreno's Miami Landfill Transformation: A Blueprint for Industrial Real Estate Value?

Terreno Realty Corporation has completed a key industrial facility in Hialeah, Florida, part of a larger strategy to redevelop a former landfill into a premium logistics hub. The move highlights the firm's focus on coastal infill markets and raises questions about execution risks and valuation as the project scales up.

Jan 31, 2026

Business

Definium Therapeutics Bolsters Board with Commercial Veteran Roger Adsett Ahead of Pivotal Trials

Biotech firm Definium Therapeutics appoints seasoned commercial executive Roger Adsett to its board, signaling a strategic shift towards commercialization as key late-stage trial data approaches.

Jan 31, 2026

Business

Zoom's Hidden AI Asset: How Its Stake in Anthropic Is Reshaping the Investment Narrative

Zoom Video Communications' early investment in AI powerhouse Anthropic is emerging as a critical, and potentially undervalued, component of its growth story, prompting analysts and investors to reassess the company's long-term trajectory beyond video conferencing.

Jan 31, 2026

Business

Greenlight Capital Bets Big on New Coal Giant Core Natural Resources Post-Merger

Greenlight Capital has spotlighted Core Natural Resources (CNR), the entity formed from the merger of Arch Resources and CONSOL Energy, as a key coal investment. The fund cites the company's valuation and combined asset base, even as the sector grapples with operational challenges. This endorsement brings renewed scrutiny to CNR's integration path and its strategy in a complex market.

Jan 31, 2026

Business

Gilead Sciences Oncology Update After Positive Trodelvy Keytruda Trial Results

Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...

Jan 31, 2026

Business

Mondelez Consolidates Power: CFO Luca Zaramella Assumes Dual Role as COO in Strategic Shake-Up

Mondelez International merges its financial and operational leadership under CFO Luca Zaramella, a move analysts say aims to tighten cost control and execution amid intense competition and commodity pressures.

Jan 31, 2026